Rüdiger Heidemann

Summary

Affiliation: Bayer HealthCare
Country: USA

Publications

  1. pmc The use of peptones as medium additives for the production of a recombinant therapeutic protein in high density perfusion cultures of mammalian cells
    R Heidemann
    Bayer Corporation, 800 Dwight Way, P O Box 1686, Berkeley, CA, 94701, USA
    Cytotechnology 32:157-67. 2000
  2. doi Characterization of cell-banking parameters for the cryopreservation of mammalian cell lines in 100-mL cryobags
    Rüdiger Heidemann
    Cell Culture Development, Global Biological Development, Bayer HealthCare LLC, 800 Dwight Way, Berkeley, CA 94701, USA
    Biotechnol Prog 26:1154-63. 2010

Detail Information

Publications2

  1. pmc The use of peptones as medium additives for the production of a recombinant therapeutic protein in high density perfusion cultures of mammalian cells
    R Heidemann
    Bayer Corporation, 800 Dwight Way, P O Box 1686, Berkeley, CA, 94701, USA
    Cytotechnology 32:157-67. 2000
    ..Therefore, whilepeptones may be considered as useful medium additiveswhen development time is limited, their addition maybe avoided by systematic medium development ifpermitted by the time line of the project...
  2. doi Characterization of cell-banking parameters for the cryopreservation of mammalian cell lines in 100-mL cryobags
    Rüdiger Heidemann
    Cell Culture Development, Global Biological Development, Bayer HealthCare LLC, 800 Dwight Way, Berkeley, CA 94701, USA
    Biotechnol Prog 26:1154-63. 2010
    ..The cryobag cell banking process should therefore be performed within a 1(1/2)-2 h window; a banking process for vials should not exceed 2(1/2) h...